Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes

Brian A. Hrycushko, Shihong Li, Chengyu Shi, Beth Goins, Yaxi Liu, William T. Phillips, Pamela M. Otto, Ande Bao

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: The primary objective was to investigate a novel focal brachytherapy technique using lipid nanoparticle (liposome)-carried β-emitting radionuclides (rhenium-186 [186Re]/rhenium-188 [ 188Re]) to simultaneously treat the postlumpectomy surgical cavity and draining lymph nodes. Methods and Materials: Cumulative activity distributions in the lumpectomy cavity and lymph nodes were extrapolated from small animal imaging and human lymphoscintigraphy data. Absorbed dose calculations were performed for lumpectomy cavities with spherical and ellipsoidal shapes and lymph nodes within human subjects by use of the dose point kernel convolution method. Results: Dose calculations showed that therapeutic dose levels within the lumpectomy cavity wall can cover 2- and 5-mm depths for 186Re and 188Re liposomes, respectively. The absorbed doses at 1 cm sharply decreased to only 1.3% to 3.7% of the doses at 2 mm for 186Re liposomes and 5 mm for 188Re liposomes. Concurrently, the draining sentinel lymph nodes would receive a high focal therapeutic absorbed dose, whereas the average dose to 1 cm of surrounding tissue received less than 1% of that within the nodes. Conclusions: Focal brachytherapy by use of 186Re/188Re liposomes was theoretically shown to be capable of simultaneously treating the lumpectomy cavity wall and draining sentinel lymph nodes with high absorbed doses while significantly lowering dose to surrounding healthy tissue. In turn, this allows for dose escalation to regions of higher probability of containing residual tumor cells after lumpectomy while reducing normal tissue complications.

Original languageEnglish (US)
Pages (from-to)948-955
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume79
Issue number3
DOIs
StatePublished - Mar 1 2011

Fingerprint

Segmental Mastectomy
lymphatic system
Brachytherapy
drainage
Liposomes
Lymph Nodes
dosage
cavities
Rhenium
Lymphoscintigraphy
Therapeutics
Residual Neoplasm
rhenium
Radioisotopes
Nanoparticles
Lipids
convolution integrals
radioactive isotopes
animals
lipids

Keywords

  • Breast cancer
  • Focal brachytherapy
  • Liposome
  • Lymph node
  • Radionuclide

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes. / Hrycushko, Brian A.; Li, Shihong; Shi, Chengyu; Goins, Beth; Liu, Yaxi; Phillips, William T.; Otto, Pamela M.; Bao, Ande.

In: International Journal of Radiation Oncology Biology Physics, Vol. 79, No. 3, 01.03.2011, p. 948-955.

Research output: Contribution to journalArticle

Hrycushko, Brian A. ; Li, Shihong ; Shi, Chengyu ; Goins, Beth ; Liu, Yaxi ; Phillips, William T. ; Otto, Pamela M. ; Bao, Ande. / Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes. In: International Journal of Radiation Oncology Biology Physics. 2011 ; Vol. 79, No. 3. pp. 948-955.
@article{f051b6af7fbc49ecb71dd5ba6e13bab0,
title = "Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes",
abstract = "Purpose: The primary objective was to investigate a novel focal brachytherapy technique using lipid nanoparticle (liposome)-carried β-emitting radionuclides (rhenium-186 [186Re]/rhenium-188 [ 188Re]) to simultaneously treat the postlumpectomy surgical cavity and draining lymph nodes. Methods and Materials: Cumulative activity distributions in the lumpectomy cavity and lymph nodes were extrapolated from small animal imaging and human lymphoscintigraphy data. Absorbed dose calculations were performed for lumpectomy cavities with spherical and ellipsoidal shapes and lymph nodes within human subjects by use of the dose point kernel convolution method. Results: Dose calculations showed that therapeutic dose levels within the lumpectomy cavity wall can cover 2- and 5-mm depths for 186Re and 188Re liposomes, respectively. The absorbed doses at 1 cm sharply decreased to only 1.3{\%} to 3.7{\%} of the doses at 2 mm for 186Re liposomes and 5 mm for 188Re liposomes. Concurrently, the draining sentinel lymph nodes would receive a high focal therapeutic absorbed dose, whereas the average dose to 1 cm of surrounding tissue received less than 1{\%} of that within the nodes. Conclusions: Focal brachytherapy by use of 186Re/188Re liposomes was theoretically shown to be capable of simultaneously treating the lumpectomy cavity wall and draining sentinel lymph nodes with high absorbed doses while significantly lowering dose to surrounding healthy tissue. In turn, this allows for dose escalation to regions of higher probability of containing residual tumor cells after lumpectomy while reducing normal tissue complications.",
keywords = "Breast cancer, Focal brachytherapy, Liposome, Lymph node, Radionuclide",
author = "Hrycushko, {Brian A.} and Shihong Li and Chengyu Shi and Beth Goins and Yaxi Liu and Phillips, {William T.} and Otto, {Pamela M.} and Ande Bao",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.ijrobp.2010.05.062",
language = "English (US)",
volume = "79",
pages = "948--955",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes

AU - Hrycushko, Brian A.

AU - Li, Shihong

AU - Shi, Chengyu

AU - Goins, Beth

AU - Liu, Yaxi

AU - Phillips, William T.

AU - Otto, Pamela M.

AU - Bao, Ande

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Purpose: The primary objective was to investigate a novel focal brachytherapy technique using lipid nanoparticle (liposome)-carried β-emitting radionuclides (rhenium-186 [186Re]/rhenium-188 [ 188Re]) to simultaneously treat the postlumpectomy surgical cavity and draining lymph nodes. Methods and Materials: Cumulative activity distributions in the lumpectomy cavity and lymph nodes were extrapolated from small animal imaging and human lymphoscintigraphy data. Absorbed dose calculations were performed for lumpectomy cavities with spherical and ellipsoidal shapes and lymph nodes within human subjects by use of the dose point kernel convolution method. Results: Dose calculations showed that therapeutic dose levels within the lumpectomy cavity wall can cover 2- and 5-mm depths for 186Re and 188Re liposomes, respectively. The absorbed doses at 1 cm sharply decreased to only 1.3% to 3.7% of the doses at 2 mm for 186Re liposomes and 5 mm for 188Re liposomes. Concurrently, the draining sentinel lymph nodes would receive a high focal therapeutic absorbed dose, whereas the average dose to 1 cm of surrounding tissue received less than 1% of that within the nodes. Conclusions: Focal brachytherapy by use of 186Re/188Re liposomes was theoretically shown to be capable of simultaneously treating the lumpectomy cavity wall and draining sentinel lymph nodes with high absorbed doses while significantly lowering dose to surrounding healthy tissue. In turn, this allows for dose escalation to regions of higher probability of containing residual tumor cells after lumpectomy while reducing normal tissue complications.

AB - Purpose: The primary objective was to investigate a novel focal brachytherapy technique using lipid nanoparticle (liposome)-carried β-emitting radionuclides (rhenium-186 [186Re]/rhenium-188 [ 188Re]) to simultaneously treat the postlumpectomy surgical cavity and draining lymph nodes. Methods and Materials: Cumulative activity distributions in the lumpectomy cavity and lymph nodes were extrapolated from small animal imaging and human lymphoscintigraphy data. Absorbed dose calculations were performed for lumpectomy cavities with spherical and ellipsoidal shapes and lymph nodes within human subjects by use of the dose point kernel convolution method. Results: Dose calculations showed that therapeutic dose levels within the lumpectomy cavity wall can cover 2- and 5-mm depths for 186Re and 188Re liposomes, respectively. The absorbed doses at 1 cm sharply decreased to only 1.3% to 3.7% of the doses at 2 mm for 186Re liposomes and 5 mm for 188Re liposomes. Concurrently, the draining sentinel lymph nodes would receive a high focal therapeutic absorbed dose, whereas the average dose to 1 cm of surrounding tissue received less than 1% of that within the nodes. Conclusions: Focal brachytherapy by use of 186Re/188Re liposomes was theoretically shown to be capable of simultaneously treating the lumpectomy cavity wall and draining sentinel lymph nodes with high absorbed doses while significantly lowering dose to surrounding healthy tissue. In turn, this allows for dose escalation to regions of higher probability of containing residual tumor cells after lumpectomy while reducing normal tissue complications.

KW - Breast cancer

KW - Focal brachytherapy

KW - Liposome

KW - Lymph node

KW - Radionuclide

UR - http://www.scopus.com/inward/record.url?scp=79551470016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551470016&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2010.05.062

DO - 10.1016/j.ijrobp.2010.05.062

M3 - Article

C2 - 20864271

AN - SCOPUS:79551470016

VL - 79

SP - 948

EP - 955

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -